Our News
Risk factors for amputation in diabetic foot ulcer patients identified in new research
Nine “significant” risk factors for lower extremity amputation in diabetic foot ulcer patients have been identified in new research.
Countdown to Hypo Awareness Week 2024 – just three weeks to go!
The highly anticipated Hypo Awareness Week returns next month, aiming to raise vital awareness about hypoglycaemia among healthcare professionals in the UK and Ireland.
CamAPS FX associated with better glucose management, study suggests
Two features of an innovative hybrid closed loop system can help people improve their glucose management at all times of the day, new research has revealed.
Remembering Dr Bob Young
The highly respected diabetes consultant Dr Bob Young has sadly passed away.
Kidney protection better with SGLT2 inhibitors, study reveals
Taking SLGT2 inhibitors is more effective in slowing your decline in estimated glomerular filtration rates than taking DPP4 inhibitors, scientists have said.
Data tool calculates benefits of employing more DISNs
A data tool has been developed by the GIRFT team to help trusts and systems in England to calculate the benefits of employing diabetes inpatient specialist nurses (DISNs).
Diabetes experts invited to Royal Society of Medicine event
Healthcare professionals with an interest in diabetes are being invited to attend an event looking at the latest updates in endocrinology and diabetes in 2024.
Entries open for QiC Awards 2024
Diabetes healthcare professionals are being invited to enter a prestigious awards programme which rewards and shares innovative practice.
Registration now open for Trend Diabetes’ first Northern Ireland conference
Trend Diabetes Annual Conference - Northern Ireland 2025
New case studies highlight success of Insulin Safety Week 2024
Following Insulin Safety Week 2024, a series of case studies have been released to commemorate these efforts and share best practice across the healthcare sector.
Insulin pump course to improve diabetes technology knowledge
A course for healthcare professionals with experience in insulin pump therapy interested in advancing their technology skills will take place next year.
New guidance issued to support ‘hyperglycaemic crises’ in adults with diabetes
A newly published guideline is now available to equip healthcare professionals with the knowledge they need to improve the treatment of adults with diabetic ketoacidosis (DKA) and hyperglycaemic hyperosmolar state (HHS).
Hybrid closed loops improve glycaemic management among young people with type 1 diabetes
Young people with newly diagnosed type 1 diabetes using closed-loop insulin delivery are more likely to have improved glycaemic management than those on standard therapy, a study has shown.
JBDS recommendations on glycaemic management and enteral feeding published
A new guideline on how to manage blood sugar levels in people with type 2 diabetes who require enteral feeding is now available.
Celebrating exceptional effort during Insulin Safety Week 2024
Following record-breaking numbers of sites taking part in Insulin Safety Week 2024, entries are now open for the Insulin Safety Week Excellence Awards.
Registrations open for Hypo Awareness Week 2024
The eagerly anticipated annual campaign Hypo Awareness Week returns this October, with the aim of raising crucial awareness of hypoglycaemia among healthcare professionals in the UK and Ireland.
Take part in GIRFT’s snapshot inpatient diabetes survey NOW!!
Diabetes inpatient teams across England are being urged to take part in a GIRFT survey to help create a snapshot of current service provision.
Study reveals high amputation risk of people admitted to hospital with diabetic foot ulcer
Research into the outcomes for people admitted with diabetic foot ulcer to hospitals which serve an ethnically diverse population has revealed the high amputation risk – 44 per cent – among its mostly Black and/or Hispanic patients.
SGLT2 inhibitors improve outcomes in people with type 2 diabetes and chronic kidney disease
The use of sodium-glucose cotransporter-2 inhibitors was linked with lower risk of acute kidney injury for people with type 2 diabetes and stage five chronic kidney disease, research claims.
New guidance sets out how to support people with early-stage type 1diabetes
New international guidance detailing how to monitor and support people with early-stage type 1 diabetes (T1D), published today in Diabetes Care and Diabetologia, has the potential to reduce the trauma associated with being diagnosed with T1D, enable people to access the latest treatments to delay the need for insulin therapy, and reduce long-term health complications.